{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:13:19Z","timestamp":1759558399852,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejogrb.2021.03.022","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T05:33:07Z","timestamp":1616045587000},"page":"110-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Office hysteroscopy safety and feasibility in women receiving anticoagulation and anti-platelet treatment"],"prefix":"10.1016","volume":"260","author":[{"given":"Nikolaos","family":"Tsampras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9268-1808","authenticated-orcid":false,"given":"Kenneth","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0432-2405","authenticated-orcid":false,"given":"Rohit","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flurina","family":"Minchelotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-0647","authenticated-orcid":false,"given":"Laurentiu","family":"Craciunas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"Hospital admitted patient care activity","key":"10.1016\/j.ejogrb.2021.03.022_bib0005"},{"issue":"February","key":"10.1016\/j.ejogrb.2021.03.022_bib0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejogrb.2015.12.008","article-title":"The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis","volume":"197","author":"van Hanegem","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.03.022_bib0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jmig.2017.08.009","article-title":"Office operative hysteroscopy: an update","volume":"25","author":"Salazar","year":"2018","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.ejogrb.2021.03.022_bib0020","unstructured":"Overview | Heavy menstrual bleeding: assessment and management | Guidance | NICE [Internet]. NICE; [cited 2020 May 6]; 2020. Available from: https:\/\/www.nice.org.uk\/guidance\/ng88."},{"issue":"April","key":"10.1016\/j.ejogrb.2021.03.022_bib0025","first-page":"25","article-title":"The implications of hysteroscopy in the updated guidelines on heavy menstrual bleeding from the UK National Institute for Health and Care Excellence (NICE)","author":"Ramshaw","year":"2019","journal-title":"Case Rep Womens Health"},{"issue":"May 22","key":"10.1016\/j.ejogrb.2021.03.022_bib0030","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMra1206531","article-title":"Management of antithrombotic therapy in patients undergoing invasive procedures","volume":"368","author":"Baron","year":"2013","journal-title":"N Engl J Med"},{"issue":"October 4","key":"10.1016\/j.ejogrb.2021.03.022_bib0035","first-page":"856","article-title":"Committee opinion no 610: chronic antithrombotic therapy and gynecologic surgery","volume":"124","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"June 6","key":"10.1016\/j.ejogrb.2021.03.022_bib0040","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.hrthm.2010.02.018","article-title":"Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation","volume":"7","author":"Ahmed","year":"2010","journal-title":"Heart Rhythm"},{"issue":"December 48","key":"10.1016\/j.ejogrb.2021.03.022_bib0045","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.15585\/mmwr.mm6748a1","article-title":"Uterine Cancer incidence and mortality - United States, 1999-2016","volume":"67","author":"Henley","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.ejogrb.2021.03.022_bib0050","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/bjh.14344","article-title":"British committee of standards for haematology. Peri-operative management of anticoagulation and antiplatelet therapy","volume":"175","author":"Keeling","year":"2016","journal-title":"Br J Haematol"},{"issue":"October7","key":"10.1016\/j.ejogrb.2021.03.022_bib0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/bdj.2007.892","article-title":"Guidelines for the management of patients on oral anticoagulants requiring dental surgery","volume":"203","author":"Perry","year":"2007","journal-title":"Br Dent J"},{"issue":"March 3","key":"10.1016\/j.ejogrb.2021.03.022_bib0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.amjmed.2011.08.022","article-title":"Safety of arthrocentesis and joint injection in patients receiving anticoagulation at therapeutic levels","volume":"125","author":"Ahmed","year":"2012","journal-title":"Am J Med"},{"issue":"July 3","key":"10.1016\/j.ejogrb.2021.03.022_bib0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.thromres.2009.01.007","article-title":"Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis","volume":"124","author":"Jamula","year":"2009","journal-title":"Thromb Res"},{"issue":"March 3","key":"10.1016\/j.ejogrb.2021.03.022_bib0070","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/gutjnl-2015-311110","article-title":"Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines","volume":"65","author":"Veitch","year":"2016","journal-title":"Gut"},{"issue":"October 15","key":"10.1016\/j.ejogrb.2021.03.022_bib0075","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1182\/blood-2012-06-415943","article-title":"How I treat anticoagulated patients undergoing an elective procedure or surgery","volume":"120","author":"Spyropoulos","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejogrb.2021.03.022_bib0080","unstructured":"Operative hysteroscopy | eLearning [Internet]. [cited 2020 May 7]; 2019. Available from: https:\/\/elearning.rcog.org.uk\/\/uterine-cavity-surgery\/operative-hysteroscopy."},{"issue":"March 3","key":"10.1016\/j.ejogrb.2021.03.022_bib0085","first-page":"e138","article-title":"The use of hysteroscopy for the diagnosis and treatment of intrauterine pathology: ACOG committee opinion, number 800","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"December 6","key":"10.1016\/j.ejogrb.2021.03.022_bib0090","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.fertnstert.2013.07.2003","article-title":"Carbon dioxide versus normal saline as distension medium for diagnostic hysteroscopy: a systematic review and meta-analysis of randomized controlled trials","volume":"100","author":"Craciunas","year":"2013","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.ejogrb.2021.03.022_bib0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11886-016-0779-9","article-title":"A bridge to nowhere? Benefits and risks for periprocedural anticoagulation in atrial fibrillation","volume":"18","author":"Krishnamoorthy","year":"2016","journal-title":"Curr Cardiol Rep"},{"issue":"7","key":"10.1016\/j.ejogrb.2021.03.022_bib0100","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","article-title":"2017 ACC Expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the american college of cardiology clinical expert consensus document task force","volume":"69","author":"Doherty","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521001421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521001421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:51:27Z","timestamp":1759557087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211521001421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":20,"alternative-id":["S0301211521001421"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.03.022","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Office hysteroscopy safety and feasibility in women receiving anticoagulation and anti-platelet treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}